Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.
2.

Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.

Maupas-Schwalm F, Robinet C, Augé N, Thiers JC, Garcia V, Cambus JP, Salvayre R, Nègre-Salvayre A.

Cancer Res. 2005 Jan 15;65(2):526-32.

3.

Signaling through beta-catenin and Lef/Tcf.

Novak A, Dedhar S.

Cell Mol Life Sci. 1999 Oct 30;56(5-6):523-37. Review.

PMID:
11212302
4.
5.

Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.

Rahmani M, Read JT, Carthy JM, McDonald PC, Wong BW, Esfandiarei M, Si X, Luo Z, Luo H, Rennie PS, McManus BM.

J Biol Chem. 2005 Apr 1;280(13):13019-28. Epub 2005 Jan 24.

6.
7.
8.

IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.

Albanese C, Wu K, D'Amico M, Jarrett C, Joyce D, Hughes J, Hulit J, Sakamaki T, Fu M, Ben-Ze'ev A, Bromberg JF, Lamberti C, Verma U, Gaynor RB, Byers SW, Pestell RG.

Mol Biol Cell. 2003 Feb;14(2):585-99.

9.

Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.

Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon ER.

Cell Growth Differ. 1999 Jun;10(6):369-76.

10.

Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.

Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoël MJ, Bertrand F, Cherqui G, Perret C, Capeau J.

Oncogene. 2001 Jan 11;20(2):252-9.

11.

The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.

Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A.

Proc Natl Acad Sci U S A. 1999 May 11;96(10):5522-7.

13.

A yeast model system for functional analysis of beta-catenin signaling.

Lee MS, D'Amour KA, Papkoff J.

J Cell Biol. 2002 Sep 16;158(6):1067-78. Epub 2002 Sep 16.

14.

Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.

Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, Cho KR, Fearon ER.

J Biol Chem. 2002 Jun 14;277(24):21657-65. Epub 2002 Apr 8.

15.

Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.

Staal FJ, Burgering BM, van de Wetering M, Clevers HC.

Int Immunol. 1999 Mar;11(3):317-23.

PMID:
10221643
17.
18.

Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells.

Mizushima T, Nakagawa H, Kamberov YG, Wilder EL, Klein PS, Rustgi AK.

Cancer Res. 2002 Jan 1;62(1):277-82.

19.

Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone.

Natsume H, Sasaki S, Kitagawa M, Kashiwabara Y, Matsushita A, Nakano K, Nishiyama K, Nagayama K, Misawa H, Masuda H, Nakamura H.

Biochem Biophys Res Commun. 2003 Sep 19;309(2):408-13.

PMID:
12951064
20.

Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.

Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP.

Cancer Res. 2004 Mar 15;64(6):1987-96.

Supplemental Content

Support Center